[go: up one dir, main page]

ES2058656T3 - 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida. - Google Patents

5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida.

Info

Publication number
ES2058656T3
ES2058656T3 ES90107098T ES90107098T ES2058656T3 ES 2058656 T3 ES2058656 T3 ES 2058656T3 ES 90107098 T ES90107098 T ES 90107098T ES 90107098 T ES90107098 T ES 90107098T ES 2058656 T3 ES2058656 T3 ES 2058656T3
Authority
ES
Spain
Prior art keywords
dipirido
onas
aids
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90107098T
Other languages
English (en)
Inventor
Karl D Dr Hargrave
Gunther Dr Schmidt
Wolfhard Dr Engel
Gunter Dr Trummlitz
Wolfgang Dr Eberlein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Dr Karl Thomae GmbH
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of ES2058656T3 publication Critical patent/ES2058656T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCUBREN NUEVAS 5,11-DIHIDRO-6H-DIPIRIDO[3,2-B:2'',3''-E][1,4]DIACEPINA-6-ONAS DE LA FORMULA I EN DONDE, R1 Y R2 SON LOS MISMOS O DIFERENTES Y SON HIDROGENO O ALQUILO LINEAL O RAMIFICADO DE 1 A 5 ATOMOS DE CARBONO. SE EMPLEAN PARA LA PREVENCION O TRATAMIENTO DEL SIDA.
ES90107098T 1989-04-20 1990-04-12 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida. Expired - Lifetime ES2058656T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34097089A 1989-04-20 1989-04-20

Publications (1)

Publication Number Publication Date
ES2058656T3 true ES2058656T3 (es) 1994-11-01

Family

ID=23335704

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90107098T Expired - Lifetime ES2058656T3 (es) 1989-04-20 1990-04-12 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida.

Country Status (7)

Country Link
EP (1) EP0393529B1 (es)
JP (1) JP2851913B2 (es)
AT (1) ATE91128T1 (es)
CA (1) CA2014771C (es)
DE (1) DE69002079T2 (es)
DK (1) DK0393529T3 (es)
ES (1) ES2058656T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
CA2052946A1 (en) * 1990-10-19 1992-04-20 Karl G. Grozinger Method for the preparation of 5,11-dihydro-6h-dipyrido ¬3,2-b:2', 3'-e| ¬1,4|diazepines
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)
GB0001930D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
DE10023492A1 (de) * 2000-05-09 2001-11-22 Schering Ag Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US6878714B2 (en) 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7307088B2 (en) 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4790339B2 (ja) * 2005-07-25 2011-10-12 リコーエレメックス株式会社 流量計測装置
US8247556B2 (en) 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1542160A (fr) * 1966-10-31 1968-10-11 Thomae Gmbh Dr K Procédé de fabrication de nouvelles 5, 11-dihydro-6h-pyrido-[2, 3-b] [1, 4]-benzodiazépine-6-ones substituées en position 11

Also Published As

Publication number Publication date
DE69002079T2 (de) 1993-11-18
JP2851913B2 (ja) 1999-01-27
DE69002079D1 (de) 1993-08-05
CA2014771A1 (en) 1990-10-20
JPH0363276A (ja) 1991-03-19
DK0393529T3 (da) 1993-11-15
CA2014771C (en) 2000-08-01
EP0393529A1 (en) 1990-10-24
EP0393529B1 (en) 1993-06-30
ATE91128T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
ES2058656T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida.
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
ES2094141T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas como antivirales.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ZA200108126B (en) Pharmaceutical compounds.
MY131268A (en) Novel pharmaceutically useful benzazepinyl-carbamoyl (and carboxyamido) benzoic acid derivatives and ring homologues thereof
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
FR2656609B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
DE69127691D1 (de) Be-13793c-derivat mit antitumorwirkung
EP0449099A3 (en) Retinoide derivatives, their preparation and their use for medicaments
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
ES484324A1 (es) Procedimiento para la obtencion de (n,n'-hidroxialquil)-ami-dinas de acido azo-di-isobutirico
MY102186A (en) Antitumor anthracycline glycosides, their preparation intermediate thereof, and compositions and use thereof
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation
ES468360A1 (es) Procedimiento para la preparacion de 2-(2',2',2'-trihalogenetil)-4-halogenciclobutan-1-ona.
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393529

Country of ref document: ES